procainamide has been researched along with Abdominal Obesity in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity was repeatedly assessed by body mass index (BMI) and waist circumference (WC) at baseline and follow-up examinations." | 1.72 | NPPA Promoter Hypomethylation Predicts Central Obesity Development: A Prospective Longitudinal Study in Chinese Adults. ( Chen, L; He, Y; Li, J; Lu, Y; Ma, S; Peng, H; Shen, B; Wu, L; Zhang, M; Zhang, Q; Zhang, R; Zhu, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Zhu, J | 1 |
| Zhang, Q | 1 |
| Chen, L | 1 |
| Ma, S | 1 |
| Lu, Y | 1 |
| Shen, B | 1 |
| Zhang, R | 1 |
| Zhang, M | 1 |
| He, Y | 1 |
| Wu, L | 1 |
| Peng, H | 1 |
1 other study available for procainamide and Abdominal Obesity
| Article | Year |
|---|---|
NPPA Promoter Hypomethylation Predicts Central Obesity Development: A Prospective Longitudinal Study in Chinese Adults.
Topics: Atrial Natriuretic Factor; Body Mass Index; China; Cross-Sectional Studies; DNA Methylation; Female; | 2022 |